Short answer: Willow sells compounded semaglutide for $299 a month all-in, and Hims sells FDA-approved GLP-1s from $298 a month all-in. For…
LOHXA
Quick verdict
- Best for
- businesses seeking pharmaceutical contract manufacturing, private labeling or oral unit-dose packaging
- Key feature
- LOHXA is a pharmaceutical contract manufacturer and private-label/repackaging business serving OTC, prescription, supplement and cosmetic markets. It is not a direct-to-consumer weight-loss or telehealth service, so a consumer cannot enroll in a weight-management program through the public company site.
LOHXA is a pharmaceutical contract manufacturer and private-label/repackaging business serving OTC, prescription, supplement and cosmetic markets. It is not a direct-to-consumer weight-loss or telehealth service, so a consumer cannot enroll in a weight-management program through the public company site. Published pricing: Manufacturing prices are quoted to business customers based on product, formulation, testing, packaging, volume and regulatory requirements; no consumer pricing applies. This independent directory review evaluates public information, not medical outcomes. We did not purchase the service or test medication. Eligibility, prices and terms may change; verify them directly before making a care decision.
Our rating
Pros and cons
Pros
- businesses seeking pharmaceutical contract manufacturing, private labeling or oral unit-dose packaging
- The company publishes a service description that informs pre-enrollment questions.
- Virtual or integrated care may be convenient for eligible users.
Cons
- This is a B2B manufacturer profile. Prospective partners should perform independent quality-system, regulatory, facility and product-specific due diligence.
- Manufacturing prices are quoted to business customers based on product, formulation, testing, packaging, volume and regulatory requirements; no consumer pricing applies.
- Public information does not guarantee individual eligibility or outcomes.
About this product
LOHXA is a pharmaceutical contract manufacturer and private-label/repackaging business serving OTC, prescription, supplement and cosmetic markets. It is not a direct-to-consumer weight-loss or telehealth service, so a consumer cannot enroll in a weight-management program through the public company site.
How it compares
Short answer: both mainly sell compounded GLP-1s, which are not FDA-approved. Mochi Health is cheaper at low doses, from $139 a month…
Short answer: Hims and Noom are different kinds of programs. Hims sells FDA-approved brand-name GLP-1s with a $149 membership, from $298 a…
User reviews
No user reviews yet.



